Royal Bank of Canada’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Buy |
55,705
+55,468
| +23,404% | +$623K | ﹤0.01% | 3973 |
|
|
2025
Q1 | $1K | Sell |
237
-144
| -38% | -$608 | ﹤0.01% | 6261 |
|
|
2024
Q4 | $3K | Sell |
381
-336
| -47% | -$2.65K | ﹤0.01% | 6136 |
|
|
2024
Q3 | $6K | Buy |
717
+128
| +22% | +$1.07K | ﹤0.01% | 5984 |
|
|
2024
Q2 | $8K | Sell |
589
-844
| -59% | -$11.5K | ﹤0.01% | 6020 |
|
|
2024
Q1 | $66K | Sell |
1,433
-240
| -14% | -$11.1K | ﹤0.01% | 4969 |
|
|
2023
Q4 | $113K | Buy |
1,673
+54
| +3% | +$3.65K | ﹤0.01% | 5012 |
|
|
2023
Q3 | $116K | Buy |
1,619
+582
| +56% | +$41.7K | ﹤0.01% | 4805 |
|
|
2023
Q2 | $78K | Buy |
1,037
+493
| +91% | +$37.1K | ﹤0.01% | 5075 |
|
|
2023
Q1 | $29K | Sell |
544
-386
| -42% | -$20.6K | ﹤0.01% | 5496 |
|
|
2022
Q4 | $63K | Sell |
930
-380
| -29% | -$25.7K | ﹤0.01% | 5288 |
|
|
2022
Q3 | $163K | Buy |
1,310
+591
| +82% | +$73.5K | ﹤0.01% | 4461 |
|
|
2022
Q2 | $69K | Buy |
719
+283
| +65% | +$27.2K | ﹤0.01% | 5095 |
|
|
2022
Q1 | $70K | Buy |
436
+39
| +10% | +$6.26K | ﹤0.01% | 5387 |
|
|
2021
Q4 | $133K | Buy |
397
+260
| +190% | +$87.1K | ﹤0.01% | 5188 |
|
|
2021
Q3 | $63K | Buy |
+137
| New | +$63K | ﹤0.01% | 5504 |
|